Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:11 am Sale |
2021-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
BALYASNY ASSET MANAGEMENT LLC | 0 0.000% |
-4,408,952 (Position Closed) |
Filing History |
| 2021-12-03 06:09 am Purchase |
2021-11-23 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
BALYASNY ASSET MANAGEMENT LLC | 4,408,952 5.670% |
4,408,952 (New Position) |
Filing History |
| 2021-02-12 3:36 pm Sale |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
EcoR1 Capital LLC | 0 0.000% |
-3,627,597 (Position Closed) |
Filing History |
| 2021-02-12 10:01 am Purchase |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
RTW Investments, LP | 7,253,857 9.670% |
1,379,628 (+23.49%) |
Filing History |
| 2021-02-04 11:40 am Purchase |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
WELLINGTON MANAGEMENT CO LLP | 4,317,623 5.750% |
3,648,932 (+545.68%) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
BLACKROCK INC BLK |
6,034,729 8.000% |
1,601,639 (+36.13%) |
Filing History |
| 2020-12-14 5:25 pm Sale |
2020-12-10 | 13D | Dicerna Pharmaceuticals, Inc. DRNA |
BCLS I Investco, LP | 2,786,247 3.700% |
-904,556 (-24.51%) |
Filing History |